Inventories

12 Months Ended

Dec. 31, 2024

Inventories [Abstract]

Inventories

14. Inventories

	2024			2023
	A$’000			A$’000
Raw materials and stores		14,396			7,700
Work in progress		13,882			5,961
Finished goods		14,030			3,649
Provision for obsolescence		(4,164	)		-
Total inventories		38,144			17,310

The amount of inventory recognized as an expense during the year was $35,690,000 (2023: $22,620,000, 2022: $9,100,000).

Inventory manufactured as part of the TLX250-CDx (Zicarix)¹ commercial manufacturing process qualification and validation has been capitalized as work in progress, with a corresponding provision for obsolescence recognized. This is on the basis that, prior to regulatory approval, the Group has not demonstrated that the batches produced can be sold commercially.